Toxicity associated with combination chemotherapy for osteosarcoma: A report of the cooperative osteosarcoma study (COSS 80)

This publication has 13 references indexed in Scilit:

• Adjuvant chemotherapy in osteosarcoma ? Effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1983
• Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
  Cancer, 1982
• Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
  1981
• Fever and neutropenia in children with neoplastic disease an analysis of 158 episodes
  Cancer, 1980
• Nephrotoxicity of cis-dichlorodiammineplatinum(II).
  1979
• Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery
  Cancer, 1979
• Management der akuten Toxizität nach hochdosierter Methotrexatbehandlung
  Oncology Research and Treatment, 1979
• High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
  1978
• [Osteosarcoma 1978 a turning point in prognosis through adjuvant chemotherapy following adequate surgery (author's transl)].
  1978
• Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
  1977